It should be mentioned that the anti-MDA5 titers from the MDA5+ DM patients at baseline did not show a prognostic value in this study, which is consistent with the other two studies that the baseline anti-MDA5 titers did not differentiate the patients who survived from those who succumbed to the disease37,38. Here, IFIH1 is linked to dermatomyositis.